Skip to main content
. Author manuscript; available in PMC: 2014 Jun 24.
Published in final edited form as: J Clin Psychiatry. 2011 Sep;72(9):1190–1196. doi: 10.4088/JCP.10087co1c

Table 1.

Features of AD Phases as Described in the NIA/Alzheimer’s Association Criteriaa

Phase Patient Features
Preclinical AD (research criteria only) Is biomarker-positive, b asymptomatic, and at risk for developing MCI due to AD and AD dementia
Is biomarker-positiveb and has subtle age-inappropriate cognitive decline
Does not meet the criteria for MCI due to AD

MCI due to AD Is concerned about a change in cognition (or concern is expressed by an informant or clinician)
Has education- and age-inappropriate cognitive impairment in =1 of the following domains:
 Memoryc
 Executive function
 Attention
 Language
 Visuospatial skills
Has slight decline in performing functional tasks, but maintains independence
Does not have vascular, traumatic, or medical causes of cognitive decline
Does not meet the criteria for dementia

Probable dementia due to AD Meets the criteria for all-cause dementia:
 Has gradual cognitive decline
 Has cognitive impairments that:
  Interfere with independence
  Are not due to delirium or another psychiatric disorder
  Have been designated via patient history and objective clinical assessment
  Are in = 2 of the following domains:
   Memory
   Reasoning and judgment
   Visuospatial skills
   Language functions
   Personality or behavior
Has either amnestic (learning and recall) or nonamnestic (language, visuospatial, and executive dysfunction) cognitive impairments
Does not have evidence of any of the following conditions:
 Cerebrovascular disease
 Dementia with Lewy bodies
 Behavioral variant frontotemporal dementia, primary progressive aphasia (semantic variant or nonfluent/ agrammatic variant), or another neurologic or medical disease or medication that could affect cognition
a

Based on Sperling et al,5 Albert et al,6 and McKhann et al.7

b

Biomarker-positive indicates that neuroimaging or cerebrospinal fluid assays have indicated that the individual has shown evidence of the pathophysiologic process associated with AD.

c

Episodic memory impairment is most common in those who progress to AD dementia.

Abbreviations: AD = Alzheimer’s disease, MCI = mild cognitive impairment, NIA = National Institute on Aging.